Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Spark Therapeutics
Pharma
$2.4B gene therapy impairment sparks Roche restructure
Roche has recently launched a “fundamental reorganization” of its Spark Therapeutics gene therapy unit and recorded a $2.4 billion full impairment.
Angus Liu
Mar 10, 2025 3:15pm
Pfizer charges $3.5M for its first FDA-approved gene therapy
Apr 26, 2024 10:19am
Roche, bluebird settle gene therapy trademark suit
May 18, 2022 11:26am
Roche loses one bid against bluebird's 'spark' DTC ad
Jan 26, 2022 12:02pm
Biotech Sparx to build 1.2 million square foot plant in China
Jul 8, 2021 9:58am
Bluebird counters trademark suit from Roche's Spark
Jul 7, 2021 10:45am
